HOME >> BIOLOGY >> NEWS
UCR to cosponsor workshop to discuss latest genetic research on invertebrates

RIVERSIDE, Calif. -- May 9, 2003 -- The College of Natural and Agricultural Sciences (CNAS) at UC Riverside and the U.S. Department of Agriculture are sponsoring the Fourth International Workshop on Transgenesis and Genomics of Invertebrate Organisms, which will be held May 11-15, 2003, at the Asilomar Conference Center, Pacific Grove, Calif. At the workshop, scientists will discuss the latest genetic research on insects and other invertebrates.

"We expect 110 scientists from around the world to attend the workshop," said Peter Atkinson, associate professor of entomology at UC Riverside. "We will discuss research on genetics and insect genomics and study ways to genetically manipulate insects that are pests -- for example, mosquitoes, fruitfiles, and moths -- with the aim of furthering our knowledge about controlling the population of these pests."

The keynote address -- "Transgenic control of insect pests: promise, peril, politics" -- will be given by Daniel Hartl, Higgins Professor of Biology in the department of organismic and evolutionary biology at Harvard University, Cambridge, Mass., whose research interests include molecular genetics, molecular evolution, and population genetics.

More than 50 scientific papers will be presented at the workshop. Some of the topics for discussion include 'Anopheles gambiae: from the genome to the population,' 'The Honey bee genome project,' 'Transgenesis and reverse genetics of mosquito innate immunity,' and 'Ecological challenges to the application of transgenic mosquitoes for disease control.' The workshop will address the control of mosquito-borne diseases and the interruption of malaria transmission by genetic manipulation of anopheline mosquitoes. Research on the housefly, the Mediterranean fruitfly, ladybird beetles, and silkworms will also be discussed.

The workshop is being organized by Alfred Handler from the USDA -- Agricultural Research Service (USDA-ARS), Peter Atkinson and Ale
'"/>

Contact: Iqbal Pittalwala
iqbal@citrus.ucr.edu
909-787-2645
University of California - Riverside
9-May-2003


Page: 1 2

Related biology news :

1. Latest findings on PCBs to be subject of June workshop at Illinois
2. Press workshop Life, a Nobel Story
3. Lunch workshop at the American Association for the Advancement of Science (AAAS) Annual Meeting
4. Global online workshop on risks of exotic forest pests will be "live" in mid-April
5. Clemson hosts workshop in frontier-science field of biological computation
6. NYU workshop will bring together leading researchers on nano-technology, DNA computing, and genomics
7. Plant pathologists meeting in Anaheim, CA to discuss agricultural security, food safety, and more
8. Researchers discuss revised Food Guide Pyramid and what it will mean for the food industry
9. Plant pathologists to discuss the future of organic farming
10. TIGR president discusses significance of finding anthrax toxin
11. Plant pathologists to meet in Anaheim, CA to discuss agricultural security, food safety, and more

Post Your Comments:
(Date:5/18/2013)... Research presented today at Digestive Disease Week (DDW) ... about the impact of coffee on autoimmune disease and ... consumption recently has been associated with reduced risk of ... more cups of java each month also correlate with ... at the Mayo Clinic, Rochester, MN, linked coffee consumption ...
(Date:5/18/2013)... An increasing number of U.S. children are ... according to research presented at Digestive Disease Week ... researchers at the Cleveland Clinic Children,s Hospital found ... exhaled breath compared to their lean counterparts. The ... that can be correlated to potential complications associated ...
(Date:5/17/2013)... insects provide the white noise of the South, but the ... the Southern air hangs heavy from the humidity and the ... than 140 species of frogs, toads and salamanders, is the ... ponds and swamps are the auditorium for their symphonic choruses, ... Monitoring Initiative, or ARMI, have front-row seats. , ...
Breaking Biology News(10 mins):Coffee consumption associated with reduced risk of autoimmune liver disease 2New research identifies risks, interventions for children's GI health 2New research identifies risks, interventions for children's GI health 3Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4
(Date:5/21/2013)... TX (PRWEB) May 21, 2013 Smarter ... outdoor security solutions, today announced that Genzyme, a Sanofi ... units of Door Detective® CL for a multi-use facility ... installed in four other Genzyme buildings, this latest order ... with the tailgate detection device improving doorway ...
(Date:5/21/2013)... 2013  MacroGenics, Inc. today announced that an ... an Fc-modified chimeric monoclonal antibody (MAb), in patients ... will be presented at the 2013 Annual Meeting ... the Developmental Therapeutics - Immunotherapy Oral Abstract Session ... PM.  The presentation will describe the results of ...
(Date:5/21/2013)... May 21, 2013 NANONEX CORPORATION, ... solutions , today announced the successful delivery and ... system, the NX-M200B, to a major Japanese manufacturing ... a fully-automated, production-ready, advanced nanoimprint lithography tool that ... wafer and substrate sizes and types. Based on ...
(Date:5/21/2013)... 2013 PathoGenetix, Inc., a commercial-stage developer ... announced today that it has successfully identified and strain ... obtained from the Centers for Disease Control and Prevention ... The findings are detailed in a poster ... for Microbiology in Denver on Monday. , The 250 ...
Breaking Biology Technology:Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3Nanonex Announces the Shipment and Installation of an Innovative Nanoimprint Lithography System for Fully Automated Manufacturing 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 3
Cached News: